MedPath

Does MIBI scan differentiate benign from malignant kidney mass

Not Applicable
Conditions
Health Condition 1: C649- Malignant neoplasm of unspecifiedkidney, except renal pelvis
Registration Number
CTRI/2021/05/033661
Lead Sponsor
AIIMS Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Patients with solid renal mass on imaging

2)Normal preoperative renal function tests

Exclusion Criteria

Patient not giving consent

Patients with previous history of renal

surgery

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) To evaluate the role of Tc 99m Sesta MIBI scan to differentiate the benign solid renal mass from aggressive malignant Renal cell carcinoma and correlate with the histopathological stage. <br/ ><br>Timepoint: 1 year
Secondary Outcome Measures
NameTimeMethod
1) To look whether Tc 99m Sesta MIBI scan helps in decision making and management of patient with RCC. <br/ ><br>2)To assess the validity of Tc 99m Sesta MIBI scan in solid renal mass and standardised the protocol.Timepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath